-transparent.png){kind=logo}
Phase II investigation of pentostatin in multiple myeloma: a Southwest Oncology Group study. 1990
Division of Cancer Treatment, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Related Publications
M R Grever, and
J Crowley, and
S Salmon, and
R McGee, and
E H Kraut, and
S S Buys, and
S E Rivkin
November 1985,
Cancer treatment reports,
M R Grever, and
J Crowley, and
S Salmon, and
R McGee, and
E H Kraut, and
S S Buys, and
S E Rivkin
November 1991,
Investigational new drugs,
M R Grever, and
J Crowley, and
S Salmon, and
R McGee, and
E H Kraut, and
S S Buys, and
S E Rivkin
January 1994,
Investigational new drugs,
M R Grever, and
J Crowley, and
S Salmon, and
R McGee, and
E H Kraut, and
S S Buys, and
S E Rivkin
January 1990,
Investigational new drugs,
M R Grever, and
J Crowley, and
S Salmon, and
R McGee, and
E H Kraut, and
S S Buys, and
S E Rivkin
February 2002,
Investigational new drugs,
M R Grever, and
J Crowley, and
S Salmon, and
R McGee, and
E H Kraut, and
S S Buys, and
S E Rivkin
November 1987,
Cancer treatment reports,
M R Grever, and
J Crowley, and
S Salmon, and
R McGee, and
E H Kraut, and
S S Buys, and
S E Rivkin
December 1977,
Cancer treatment reports,
M R Grever, and
J Crowley, and
S Salmon, and
R McGee, and
E H Kraut, and
S S Buys, and
S E Rivkin
July 1976,
Cancer,
M R Grever, and
J Crowley, and
S Salmon, and
R McGee, and
E H Kraut, and
S S Buys, and
S E Rivkin
February 1990,
Investigational new drugs,
M R Grever, and
J Crowley, and
S Salmon, and
R McGee, and
E H Kraut, and
S S Buys, and
S E Rivkin
July 1999,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
